ORA - Oxford University Research Archive

You searched for:

Oxford, MSD, Pathology Dunn School

Histocompatibility Testing

1 - 9 of 9

1

Journal article

In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation.

Kottaridis, PD, Milligan, DW, Chopra, R, et al.
2000-10-05

2

Conference

Unrelated donor bone marrow transplant in childhood ALL. The role of T-cell depletion.

Cornish, JM, Pamphilon, DH, Potter, MN, et al.
1996-11-05

3

Journal article

Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity between donor and recipient.

Spencer, A, Szydlo, RM, Brookes, PA, et al.
1995-11-05

4

Journal article

Myeloablative conditioning is well tolerated by older patients receiving T-cell-depleted grafts.

Novitzky, N, Thomas, V, Hale, G, et al.
2005-10-05

5

Journal article

CD4 and CD8 monoclonal antibody therapy in canine renal allografts.

Watson, CJ, Cobbold, SP, Davies, HF, et al.
1994

6

Journal article

CD40 ligand blockade induces CD4+ T cell tolerance and linked suppression.

Honey, K, Cobbold, SP, Waldmann, H
1999-11-05

7

Journal article

The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia.

Byrne, JL, Stainer, C, Cull, G, et al.
2000-02-05

8

Journal article

CAMPATH-1 monoclonal antibodies in bone marrow transplantation.

Hale, G, Waldmann, H
1994

9

Journal article

Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.

Gupta, V, Ball, SE, Yi, QL, et al.
2004-12-05

TO TOP